Most readers would already be aware that HAEMATO's (ETR:HAEK) stock increased significantly by 27% over the past three months. As most would know, fundamentals are what usually guide market price ...

While HAEMATO AG (HMSE:HAEK) might not have the largest market cap around , it saw a decent share price growth of 16% on the HMSE over the last few months. Shareholders may appreciate the recent price ...

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of ...

The issuer is solely responsible for the content of this announcement. HAEMATO AG with a strong start into the year 2023: Revenue increase of over 25% compared to the same quarter of the previous year ...

DJ HAEMATO adds a new generation test device to its portfolio DGAP-Media / 2022-02-15 / 14:45 Schönefeld, 15 February 2022 - HAEMATO PHARM GmbH ("HAEMATO"), a 100% subsidiary of HAEMATO AG (ISIN: ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.